Todd Hayashida Driver

Todd Driver practices at Oc Eye Associates, Inc. in Irvine, California.

Todd Driver's NPI, 1245650985, was assigned on April 21, 2014. Todd Driver graduated from UCSF School of Medicine in 2014. Todd Driver holds California license A140821.

Todd Driver's primary practice is Oc Eye Associates, Inc., at 9 Corporate Park Suite 150 Suite 150, Irvine, CA 92606-5172. The practice phone is (949) 653-9500.

Todd Driver's primary practice is Oc Eye Associates, Inc. in Irvine, California. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Todd Driver to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Todd Driver practices. Vendor and product names are available with a free account.

Ophthalmology is Todd Driver's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Todd Driver is board certified in ophthalmology by the American Board of Ophthalmology. Todd Driver is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Todd Driver treats.

CMS data shows 1,688 Medicare services from Todd Driver across 11 procedure codes in 2024, for 556 Medicare patients. Medicare paid $159,925 for them.

CMS counts 556 Medicare patients who saw Todd Driver in 2024. The largest group is 65 to 74, with 259 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Todd Driver's median patient age at 73, with 61% women.

In 2024, Todd Driver wrote 1,607 Medicare Part D claims for 485 patients. 50% of them were for generic drugs. CMS names the drug for 1,522 of them, across 21 drugs with 11 or more claims each, at $185,897 in total drug cost. In 2023, CMS named 1,609 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 19 out of 100 for Todd Driver for performance year 2024, reported individually. Todd Driver accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 161 procedures of cataract surgery by Todd Driver, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Todd Driver, published from 2011 to 2021. 2014 was the busiest year, with 6. The most frequent topics are Creatinine, Ophthalmology and Glomerular Filtration Rate. Todd Driver has published most often in Am J Kidney Dis. Todd Driver's most frequent co-authors are Michael George Shlipak, MD, Joachim Hanno Ix, MD and Michele Danielle Lee, MD.

CMS Open Payments shows 90 general payments to Todd Driver from 24 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $1,359.

Dmand AI lists 1 award for Todd Driver, most recently Alpha Omega Alpha Honor society in 2014.

Todd Driver graduated from UCSF School of Medicine in 2014. Todd Driver is a member of AOA, AAO, ASCRS and Orange County Society of Ophthalmology.

Todd Driver is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.